Navigation Links
Stryker to Host Analyst Meeting
Date:1/30/2009

al of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; changes in financial markets; and changes in the competitive environment. Additional information concerning these and other factors is contained in the Company's filings with the U.S. Securities and Exchange Commission, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information about Stryker, please visit www.stryker.com.


'/>"/>
SOURCE Stryker Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Stryker Operating Results for Quarter Ended December 31, 2008
2. LegalView Developing Cranial Implant Information Portal Detailing the Recall of Stryker Cranial Implant Kits
3. Stryker Updates Expected 2008 Results and Provides 2009 Outlook
4. Stryker To Present at Investor Conference
5. Stryker Increases Annual Dividend by Over 20%
6. Stryker Announces Organizational and Leadership Changes
7. Stryker to Present at Investor Conferences
8. Stryker To Present at Investor Conference
9. Stryker to Present at Investor Conferences
10. Stryker to Present at Investor Conference
11. Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...RIE,Minn.,Nov.23/PRNewswire/--XiotechCorporationto...entedanEmprise(TM)7000storagesystem,poweredbyIntel...tscurrentdatastorageneeds,enablefuturegrowthanddel...sacrossitsdatacenter. ,, MasonGeneral,locatedin...tworks magazine,s"MostWired-Rural"hospitalsin2008a...
(Date:11/23/2009)...NS,Nov.23/PRNewswire/--Thanksgivingweekendmarksthe...radition,theClassicrepresentsthesportsmanshipandpr...yofNewOrleansandthoseinattendance. ,, Forthecre...anceforsomedowntimebeforetheyworktotestandlaunchab...ofconstruction,PettyOfficerClaudeBovellandtheresto...
(Date:11/23/2009)... suggest that adding flaxseed oil to the diet coul...al women and women with diabetes, according to a r...l of Food Safety, Nutrition and Public Health . ,...h Center, in Cairo, Egypt, have studied the effect...seed oil in the diet might delay the onset of oste...
(Date:11/23/2009)...op plants genetically modified to produce bacteria...safe for people, have been planted on more than 20...ese Bt crops, named after the bacterium Bacillus ...ome major pests, allowing farmers to save money an...cide sprays. , However, since insects can evolve...
(Date:11/23/2009)...hemo regimen may improve patient outcomes, researc...y News) -- A new combination drug therapy shows pr...ract cancers, researchers say. , The study from...in Boston found that survival and tumor response i...angiogenesis inhibitor that has helped slow the gr...
Breaking Medicine News(10 mins):Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Nothing Is Like Being There 2Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2
...Total U.S. Market for Women,s Health Devices Worth...swire/ - According to two market research reports ...nternational medical device, dental and pharmaceut...erilization devices, which grew over 54% in 2008, ...
...Unique fashion accessory adds a fun, playful pop o... good; Stylish low-cost pendants support disabled ...CLARA, Calif., May 5 - Ground-breaking Art of Po...unced it has finalized a licensing agreement with ...
... Out of adversity comes op...icant words uttered more than 250 years ago ring t...day. , New York, NY (Vocu...ring true for the Gift of Life Bone Marrow Found...
... The Better Hearing Instit... for Better Hearing and Speech Month: Listening Up...aring health affects job security, performance, an...t unaddressed hearing loss does not pose a barrier...
... ZyDoc Medical Transcripti...as chosen ZyDoc,s award-winning web-based e-transc...ents. , Hauppauge, New Yo...in business since 1994, has chosen ZyDoc,s award-w...
... Renowned Dentist Robert L... Cosmetic Dentistry is one of the few Doctors in P...n for oral sedation dentistry. , ...ly that the practice has earned its certification ...
Other Medicine News:Health News:U.S. Market for Female Sterilization Devices to Grow 36% in 2009 2Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 2Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 3Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 4Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 5Health News:Bone Marrow Registry to Launch Groundbreaking Fundraising Technology to Overcome Madoff Crisis 2Health News:Listening Up in a Down Economy: Better Hearing Institute Launches Public Service Campaign for Better Hearing and Speech Month 2Health News:Listening Up in a Down Economy: Better Hearing Institute Launches Public Service Campaign for Better Hearing and Speech Month 3Health News:Administrative Advantage Selects ZyDoc e-Transcription Platform for Clients 2Health News:Administrative Advantage Selects ZyDoc e-Transcription Platform for Clients 3Health News:Administrative Advantage Selects ZyDoc e-Transcription Platform for Clients 4Health News:Raleigh Comprehensive and Cosmetic Dentistry Earns Certification For Sedation Dentistry 2Health News:Raleigh Comprehensive and Cosmetic Dentistry Earns Certification For Sedation Dentistry 3
(Date:11/23/2009)...3/PRNewswire-FirstCall/-- LexiconPharmaceuticals,I...fromitsPhase2clinicalstudywith LX1031 inpatientswi...epresentedatGASTRO2009inLondonthisweek.Resultsfrom...mptoms,willbepresentedbyDr. PhilipM.Brown ,Lexicon...ber25,2009at2:30pmlocaltimeatthesessionentitled,"T...
(Date:11/23/2009)...RNewswire-FirstCall/--WoundManagementTechnologies,...rofspecialtymedicalproducts,announcedthatithasfile...ivemanagementbusinessupdatetoillustratethedevelopm...ncreased33.5%to$102,926vs.Q32008salesof$77,084. ,...27,892vs.Q32008shareholderequityof$(321,257) ,...
(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/--Anesiva,Inc.(Nasdaq....U,PrichardhaveagreedtojointheAnesivaboardofdirect...esivaandArcionTherapeutics.Completionofthemergeris...previouslyannouncedAnesiva2009AnnualMeetingofStock...OysterPoint,Suite107A,SouthSanFrancisco,California...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 1Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 2Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 1Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 2Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 4Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 1Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 3Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 4
...r Validate Lipidomic-Based Therapeutics as an Emer...ery, SAN DIEGO, Sept. 4 Lpath, Inc. (OTC Bulleti... agents against bioactive,lipids, reported positiv...,and AMD with Lpathomab(TM), the company,s mouse m...cid). These results confirm the expected potent,an...
...la., Sept. 4 In an extensive analysis of,clinical...rolimus-eluting,Coronary Stent was associated with...need for reintervention compared to the Taxus Sten... This meta-analysis of 16 randomized,clinical tria... kind to,date, is now posted on the Journal of the...
Other Medicine Technology:Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 2Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 2Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 4
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: